CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Werfen SAS is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Werfen SAS
88-94 Rue Andre Joineau
Phone: 01.82.30.86.00p:01.82.30.86.00 Le Pre Saint Gervais, 93315  France
This is a Subsidiary, click here for the Parent Company
Business Summary
Werfen SAS specializes in the development of vitro diagnostic solutions that enhance patient care. The Company’s product portfolio includes healthcare instruments, software, reagents, and services. It offers haemostasis, critical care, autoimmunity, serology, clinical chemistry diagnostics, and more.

Scores and Ratings
FRISK®
Score		 Z''
Score		 PAYCE®
Score		 DBT
Index		 Moody's
Rating		 Fitch
Rating		 DBRS
Rating
---Yes-Yes-

Financials, News and Filings
Latest
Statement		 Last
Audit
News		 SEC
Filings		 Bankruptcy
Filings		 Suit &
Judgment
Filings		 Tax
Lien
Filings
--Yes---Yes

Industries
SIC Code Description
5047 Medical, dental, and hospital equipment and supplies


Copyright © 2026 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Friday, March 6, 2026